JP2006506319A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506319A5
JP2006506319A5 JP2003574643A JP2003574643A JP2006506319A5 JP 2006506319 A5 JP2006506319 A5 JP 2006506319A5 JP 2003574643 A JP2003574643 A JP 2003574643A JP 2003574643 A JP2003574643 A JP 2003574643A JP 2006506319 A5 JP2006506319 A5 JP 2006506319A5
Authority
JP
Japan
Prior art keywords
compound according
alkylene
substituted
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003574643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006506319A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/006167 external-priority patent/WO2003076426A2/en
Publication of JP2006506319A publication Critical patent/JP2006506319A/ja
Publication of JP2006506319A5 publication Critical patent/JP2006506319A5/ja
Withdrawn legal-status Critical Current

Links

JP2003574643A 2002-03-04 2003-02-27 5−ht受容体リガンドとしてのピリジニルオキシ誘導体 Withdrawn JP2006506319A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36146602P 2002-03-04 2002-03-04
PCT/US2003/006167 WO2003076426A2 (en) 2002-03-04 2003-02-27 Pyridinyloxy derivatives as 5-ht receptor ligands

Publications (2)

Publication Number Publication Date
JP2006506319A JP2006506319A (ja) 2006-02-23
JP2006506319A5 true JP2006506319A5 (cg-RX-API-DMAC7.html) 2006-04-06

Family

ID=27805035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003574643A Withdrawn JP2006506319A (ja) 2002-03-04 2003-02-27 5−ht受容体リガンドとしてのピリジニルオキシ誘導体

Country Status (8)

Country Link
US (1) US7291738B2 (cg-RX-API-DMAC7.html)
EP (1) EP1485386A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006506319A (cg-RX-API-DMAC7.html)
AU (1) AU2003217817A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308223A (cg-RX-API-DMAC7.html)
CA (1) CA2475254A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04008517A (cg-RX-API-DMAC7.html)
WO (1) WO2003076426A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4943837B2 (ja) 2003-04-03 2012-05-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 可溶性エポキシド加水分解酵素の改良インヒビター
EP1765311A4 (en) 2004-03-16 2009-04-29 Univ California REDUCTION OF NEPHROPATHY WITH INHIBITORS OF SOLUBLE EPOXY HYDROLASE AND EPOXYEICOSANOIDS
EP1814875A4 (en) 2004-10-20 2010-02-17 Univ California IMPROVED INHIBITORS OF SOLUBLE EPOXY HYDROLASE
AR059356A1 (es) * 2006-02-14 2008-03-26 Astrazeneca Ab Nuevos radioligandos
TW200808723A (en) 2006-03-13 2008-02-16 Univ California Conformationally restricted urea inhibitors of soluble epoxide hydrolase
KR101062376B1 (ko) 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
WO2012054093A2 (en) 2010-01-29 2012-04-26 The Regents Of The University Of California Acyl piperidine inhibitors of soluble epoxide hydrolase
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5689606A (en) 1996-06-03 1997-11-18 Scientific-Atlanta, Inc. Fiber routing and retention assembly with modular fiber connector support
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
GB9612885D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6861420B2 (en) * 2001-11-28 2005-03-01 Pharmacia & Upjohn Company N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds

Similar Documents

Publication Publication Date Title
JP6021805B2 (ja) 腫瘍治療剤
JP2008509187A5 (cg-RX-API-DMAC7.html)
JP2010509356A5 (cg-RX-API-DMAC7.html)
TR201807023T4 (tr) Abl1, abl2 ve bcr- abl1 aktivitesinin inhibe edilmesi için benzamid türevleri.
JP2005519908A5 (cg-RX-API-DMAC7.html)
JP2007505877A5 (cg-RX-API-DMAC7.html)
JP2016106091A (ja) ピリミジン誘導体の製造プロセス
CN102317257A (zh) 制备不对称双(缩氨基硫脲)的方法
JP2020534373A5 (cg-RX-API-DMAC7.html)
JP2006519852A5 (cg-RX-API-DMAC7.html)
JP6380777B2 (ja) PI3K、mTOR阻害薬としての縮合キノリン化合物
JP2003513071A5 (cg-RX-API-DMAC7.html)
ES2766758T3 (es) Sales de adición de base de nitroxolina y usos de las mismas
TW202313050A (zh) 組合療法
JP2006506319A5 (cg-RX-API-DMAC7.html)
JP2005532397A5 (cg-RX-API-DMAC7.html)
JPWO2023287896A5 (cg-RX-API-DMAC7.html)
JP2016514160A5 (cg-RX-API-DMAC7.html)
JP2018522915A5 (cg-RX-API-DMAC7.html)
CN110156782B (zh) 作为pi3k/mtor抑制剂的吡啶基取代的稠合喹啉化合物
JP2004536079A5 (cg-RX-API-DMAC7.html)
JP2003516994A5 (cg-RX-API-DMAC7.html)
CN103025722B (zh) 具有2-(杂芳基)氨基取代基的氯苯吩嗪及其抗微生物活性
US8981114B2 (en) Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
JP2005535560A5 (cg-RX-API-DMAC7.html)